North American Dietary Supplements Market Poised to Add USD 90.4B by 2036 - Future Market Insights (FMI)

05.03.2026

Demand of North American Dietary Supplements increase as Personalized Subscriptions, Healthy Aging, and GLP-1 Adjacent Nutrition Reshape Buying Decisions

NEWARK, Del., March 5, 2026 /PRNewswire/ -- Future Market Insights (FMI) projects the North American dietary supplements market reached USD 79.2 billion in 2025 and is projected to grow to USD 85.1 billion in 2026 and USD 175.5 billion by 2036, expanding at a 7.5% CAGR over the forecast period. The decade's absolute dollar growth of USD 90.4 billion reflects a market moving beyond 'daily multivitamins' into condition-specific, clinically positioned, and digitally personalized regimens—with procurement and margin strategies increasingly shaped by raw material volatility and channel shifts.

Future Market Insights Logo

Market Snapshot: North American Dietary Supplements Demands

  • 2025 value: USD 79.2B
  • 2026 value: USD 85.1B
  • 2036 forecast: USD 175.5B
  • CAGR: 7.5%
  • Absolute growth (decade): USD 90.4B
  • 2026 leading type: Vitamins (27.2% of market value)
  • 2026 leading form: Tablets (25.3% of form demand)
  • Fastest-growing form: Gummies
  • 2026 leading channel: Store-based (59.4% share)

Download North American Dietary Supplements Market Report Sample: https://www.futuremarketinsights.com/reports/brochure/rep-na-244 

What's Changing: From Shelf Competition to Data-Driven, Subscription-Led Demand

FMI indicates that growth is being powered by three structural shifts:

1) Healthy aging becomes category expansion (not just maintenance).

Aging population health management is widening demand into cognitive health, joint support, gut microbiome, and cardiovascular wellness, pulling more specialized SKUs into the mainstream.

2) Personalization upgrades pricing power—and rewrites distribution economics.

Personalized nutrition platforms using biomarker testing and digital health data are creating subscription-based regimens that can command 2–3x pricing premiums over mass-market equivalents while reducing dependency on traditional retail intermediaries.

3) GLP-1 weight management creates a 'nutrient-gap' adjacency wave.

GLP-1 receptor agonist adoption is generating new supplement demand for protein, fiber, and micronutrient products aimed at addressing nutritional gaps linked to reduce caloric intake. FMI's strategic takeaways point to 30+ million North Americans expected to use weight management medications by 2030, underscoring the scale of this adjacent opportunity.

Executive Signal for Buyers: Margin Risk Is Shifting Upstream

FMI highlights raw material costs for vitamins, minerals, and specialty bioactives as the primary margin variables. Supply chain concentration—particularly Chinese API manufacturing for vitamins C, D, and B-complex—continues to create procurement volatility for North American brand owners and contract manufacturers. For decision makers, this is increasingly a specification and sourcing issue, not just a pricing negotiation.

Competitive Momentum: Personalization Platforms Move from Strategy to Operating System

As Stephan Gratziani, CEO of Herbalife, stated regarding the company's strategic direction, "The objective is to enter new segments with personalized offerings while also strengthening relationships with current customers." In February 2026, Herbalife announced the phased rollout of Pro2col, a digital health and wellness operating system designed to provide personalized nutritional supplement recommendations, with U.S. accessibility confirmed by end of H1 2026.

For category leaders and fast-growing challengers alike, this signals a measurable shift: digital engagement + personalization = retention engine, not just marketing.

What the Market Covers

The North American dietary supplements market includes vitamins, minerals, amino acids, proteins, probiotics, and botanical blends sold across multiple delivery forms (tablets, capsules, softgels, powders, gummies) via retail, e-commerce, and practitioner channels across the USA, Canada, and Mexico.

Regulatory framing referenced in the market definition includes:

  • USA: Dietary Supplement Health and Education Act (DSHEA)
  • Canada: Natural Health Products (NHP) Regulations
  • Mexico: COFEPRIS guidelines

Segment Signals That Matter Most to Commercial Leaders

Type: Vitamins Lead Value (27.2% in 2026)

Vitamins are projected to hold 27.2% of market value in 2026, supported by continued demand for vitamin D, C, and B-complex across preventive wellness and immune support. Product innovation (bioavailability and combination formulas) and stronger integration into preventive regimens continue reinforcing this base.

Form: Tablets Lead Today; Gummies Accelerate Fastest

Tablets represent 25.3% of form demand in 2026, favored for stability, cost-effectiveness, and scalable manufacturing. At the same time, gummies are the fastest-growing delivery format, driven by consumer preference for palatability and convenience—creating a dual-speed portfolio reality for brands and CDMOs.

Distribution: Store-Based Still Anchors Volume (59.4%), While Non-Store Grows Faster

Store-based distribution is expected to hold 59.4% share in 2026, anchored by pharmacy chains (CVS, Walgreens, Shoppers Drug Mart) and mass retailers (Walmart, Costco). Non-store growth is accelerating via Amazon, DTC brands, and telehealth-linked platforms, particularly where personalization and subscription models reduce reliance on shelf placement.

Regional Growth Outlook: Canada Leads CAGR; USA Leads Absolute Demand

FMI's country view highlights different growth roles across North America:

  • Canada: 8.5% CAGR, supported by expanding natural health product frameworks and aging-driven adoption
  • Mexico: 8.1% CAGR, supported by rising middle-class health awareness and expanding pharmacy-channel distribution
  • USA: 7.2% CAGR, generating the largest absolute demand, driven by personalization platforms, clinical-grade adoption, and GLP-1 adjacent expansion

FMI Analyst View: Retail Margins Compress as Subscriptions Rise

Nandini Roy Choudhury, Principal Consultant for the Food & Beverage Industry at Future Market Insights, notes that personalized nutrition platforms are compressing traditional retail distribution margins by converting consumers to subscription models that bypass pharmacy and mass retail intermediaries. The analyst also points to consolidation dynamics—including the Kimberly-Clark acquisition of Kenvue—and flags Health Canada's NHP regulatory modernization as a source of compliance cost uncertainty for smaller brands operating across the U.S.–Canada border.

Strategic Implications for Buyers and Operators

For executives, procurement heads, and product leaders, FMI's executive takeaways translate into three near-term actions:

  1. Build or partner for digital personalization

    Invest in biomarker-linked recommendation platforms to access subscription revenue that can command 2–3x premiums versus shelf pricing.
  2. Launch GLP-1 adjacent portfolios

    Prioritize protein, fiber, and micronutrient-gap formulations designed for consumers on weight management medications, aligned with expected scale of adoption by 2030.
  3. Diversify sourcing beyond single-country vitamin APIs

    Reduce exposure on high-volume inputs—vitamins C, D, and B-complex—by diversifying raw material sourcing beyond concentrated supply chains to mitigate disruption and trade-policy risk.

Key Players in North American Dietary Supplements Market: USANA Health Sciences, NOW Foods, Optimum Nutrition, Amway, Abbott Laboratories, Bayer AG, Nature's Way, Pfizer Inc., New Chapter, Jamieson Wellness, Metagenics, The Nature's Bounty Co., Herbalife, Garden of Life, GNC Holdings

Methodology

  • Validated through interviews with brand owners, contract manufacturers, and retail pharmacy buyers across the USA, Canada, and Mexico
  • Built from verifiable retail scanner data, e-commerce tracking, and company revenue disclosures
  • Supported by FDA, Health Canada, and CRN industry data, plus contract manufacturing throughput and raw material import volume verification
  • Outputs undergo anomaly screening and peer review prior to release

Buy Full Report:  https://www.futuremarketinsights.com/checkout/244 

Related Reports:

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. Headquartered in Delaware, USA, with a global delivery center in India and offices in the UK and UAE, FMI delivers actionable insights to businesses across industries including automotive, technology, consumer products, manufacturing, energy, and chemicals.

An ESOMAR-certified research organization, FMI provides custom and syndicated market reports and consulting services, supporting both Fortune 1,000 companies and SMEs. Its team of 300+ experienced analysts ensures credible, data-driven insights to help clients navigate global markets and identify growth opportunities.

For Press & Corporate Inquiries

Rahul Singh

AVP - Marketing and Growth Strategy

Future Market Insights, Inc.

+91 8600020075

For Sales - sales@futuremarketinsights.com

For Media - Rahul.singh@futuremarketinsights.com

For web - https://www.futuremarketinsights.com/

Logo: https://mma.prnewswire.com/media/1197648/3531122/FMI_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/north-american-dietary-supplements-market-poised-to-add-usd-90-4b-by-2036---future-market-insights-fmi-302705366.html

Other news

Rekorddividende kann Kursrutsch bei Lindt & Sprüngli nicht verhindern

12.03.2026


Lindt & Sprüngli liefert operative Rekordzahlen – und erlebt an der Börse dennoch einen heftigen Rückschlag. Die Partizipationsscheine des Premiumschokoladen-Herstellers brachen am Dienstag im frühen Handel zeitweise bis auf 11'000 Franken ein, ein Minus im Tief von deutlich über 7 Prozent. Auslöser ist nicht das vergangene Geschäftsjahr, in dem Lindt EBIT, Reingewinn und Marge im Rahmen oder leicht über den Konsensschätzungen abgeliefert hat, sondern die spürbar zurückgenommene Wachstumsprognose für das laufende Jahr.

Nach einem preisgetriebenen Umsatzplus und einer EBIT-Marge von rund 16,4 Prozent im Jahr 2025, die damit innerhalb der eigenen Zielspanne lag, stellt der Konzern für 2026 nur noch ein organisches Wachstum von 4 bis 6 Prozent in Aussicht. Zuvor lag der Korridor bei 6 bis 8 Prozent. Bereits für das laufende Jahr hatte Lindt seine „übliche“ Wachstumsbandbreite von 6 bis 8 Prozent im Januar noch bestätigt, nur um sie nun auf 4 bis 6 Prozent zu senken. Begründet wird dies mit geopolitischen Spannungen rund um den Iran-Krieg, höheren Energiepreisen, gedämpfter Konsumstimmung und möglichen Belastungen für den Tourismus – was speziell die Verkäufe an Flughäfen und in touristischen Hotspots treffen könnte.

Ein Teil der Analysten zweifelt jedoch daran, dass geopolitische Risiken die alleinige oder wesentliche Erklärung für die vorsichtigere Tonlage sind. So verweist Bernstein auf den vergleichsweise geringen Anteil des Nahen Ostens am Gesamtumsatz von Lindt von lediglich rund 1 bis 2 Prozent. Für Beobachter wie Vontobel-Analyst Jean-Philippe Bertschy signalisiert die neue Guidance daher vor allem Unsicherheit darüber, ob der Konzern nach einem Jahr, in dem das Wachstum praktisch komplett aus massiven Preiserhöhungen und nicht aus steigenden Volumen kam, die Absatzmengen 2026 tatsächlich wieder erhöhen kann.

Gleichzeitig fährt Lindt die Aktionärsvergütung deutlich hoch. Die Dividende soll für das abgelaufene Jahr stärker als erwartet steigen: Je Namenaktie werden 1'800 Franken in Aussicht gestellt – rund 200 Franken mehr als die Analystenschätzungen. Zudem plant das Unternehmen ein neues Aktienrückkaufprogramm von bis zu 1 Milliarde Franken und erhöht die Dividende beim Partizipationsschein auf 180 Franken. Nach einer rund 19-prozentigen Preiserhöhung im Jahr 2025, die trotz rückläufiger Verkaufsvolumina für ein Umsatzwachstum von 8,2 Prozent auf 5,92 Milliarden Franken sorgte, richtet Lindt damit seine Kapitalallokation stärker auf Ausschüttungen aus. An der Börse überlagern allerdings Zweifel an der künftigen Wachstumsdynamik derzeit den positiven Cashflow-Ausweis – der Bewertungsbonus einer vermeintlich verlässlichen Wachstumsgeschichte steht zur Disposition.